Shikano Hiroki, Uehara Yuki, Kuboki Rino, Tashino Erika, Nakahara Fumiko, Matsumoto Yumi, Kusakabe Satomi, Fukazawa Chizumi, Matsuo Takahiro, Mori Nobuyoshi, Ayabe Akiko, Jinta Torahiko, Taki Fumika, Sakamoto Fumie, Takahashi Osamu, Fukui Tsuguya
Department of Clinical Laboratory, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan.
Department of Clinical Laboratory, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan; Department of Infectious Diseases, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan; Department of Microbiology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan.
Am J Infect Control. 2022 Jun;50(6):645-650. doi: 10.1016/j.ajic.2021.11.029. Epub 2021 Dec 8.
Effectiveness of restricting healthcare providers (HCPs) from working based on the coronavirus disease 2019 (COVID-19)-like symptoms should be evaluated.
A total of 495 HCPs in a tertiary care hospital in Tokyo, Japan, participated in this study between June and July in 2020. Analysis of serum anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody to identify infected HCPs, questionnaire surveys, and medical record reviews were conducted to evaluate the appropriateness of symptom-based work restriction for 10 days.
Five participants (1.0%) were identified as infected. Forty-six participants (9.3%) experienced work restriction and all 5 infected participants (10.8%) restricted working, even though the real-time reverse transcription-polymerase chain reaction was positive only in 4 participants (80.0%). There were no unexpectedly infected participants among those who did not experience work restriction. However, only 46 of 110 HCPs with COVID-19-like symptoms (41.8%) restricted themselves from working.
Symptom-based work restriction strategy successfully prevented infected HCPs to work, but showed low specificity to identify truly infected HCPs, and their low adherence to the strategy was revealed.
HCPs with COVID-19-like symptoms should restrict working as the first step of infection prevention, but the strategy to identify truly infected HCPs is necessary.
应评估基于2019冠状病毒病（COVID-19）样症状限制医疗保健提供者（HCP）工作的有效性。
2020年6月至7月期间，日本东京一家三级护理医院的495名HCP参与了本研究。通过分析血清抗严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体来识别受感染的HCP，并进行问卷调查和病历审查，以评估基于症状的10天工作限制的适当性。
5名参与者（1.0%）被确定为感染。46名参与者（9.3%）经历了工作限制，所有5名受感染参与者（10.8%）都限制了工作，尽管实时逆转录-聚合酶链反应仅在4名参与者（80.0%）中呈阳性。在未经历工作限制的人员中没有意外感染的参与者。然而，110名有COVID-19样症状的HCP中只有46名（41.8%）自行限制了工作。
基于症状的工作限制策略成功地阻止了受感染的HCP工作，但在识别真正受感染的HCP方面特异性较低，并且发现他们对该策略的依从性较低。
有COVID-19样症状的HCP应限制工作，作为感染预防的第一步，但需要制定识别真正受感染的HCP的策略。
